D-Cystine hydrochloride

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: D-Cystine hydrochloride
• 英文别名: 2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid;hydrochloride
• 化学式: C6H13ClN2O4S2
• 分子量: 276.8
• InChiKey: IOCJWNPYGRVHLN-ZRCOPKFRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.39
• 重原子数：
  15
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  177
• 氢给体数：
  5
• 氢受体数：
  8

文献信息

• Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates
  申请人：——

  公开号：US20040024262A1

  公开（公告）日：2004-02-05

  This invention provides a method of treating fibrous substrates, such as leather, by contacting the substrate with a fluorochemical compound comprising: a fluorochemical oligomeric portion comprising an aliphatic backbone with a plurality of pendant fluoroaliphatic groups, each fluoroaliphatic group having a fully fluorinated terminal group and each independently linked to a carbon atom of the aliphatic backbone through an organic linking group; an aliphatic moiety; and a linking group which links the fluorochemical oligomeric portion to the aliphatic moiety. The fluorochemical compounds provide desirable oil, water and stain repellency to fibrous substrates.

  这项发明提供了一种处理纤维基质（如皮革）的方法，包括将基质与含有氟化合物接触，该氟化合物包括：含有脂肪族骨架和多个挂链氟脂肪基团的氟化合物寡聚物部分，每个氟脂肪基团具有全氟化的末端基团，并且每个通过有机连接基团独立连接到脂肪族骨架的碳原子上；脂肪基团；以及将氟化合物寡聚物部分连接到脂肪基团的连接基团。这些氟化合物为纤维基质提供了理想的油、水和污渍防护性能。
• [EN] POLYAMIDE MICROCAPSULES<br/>[FR] MICROCAPSULES DE POLYAMIDE
  申请人：FIRMENICH & CIE

  公开号：WO2021254931A1

  公开（公告）日：2021-12-23

  The present invention relates to polyamide microcapsules. A process for the preparation of polyamide microcapsules is also an object of the invention. Perfuming compositions and consumer products comprising said microcapsules, in particular perfumed consumer products in the form of home care or personal care products, are also part of the invention.

  本发明涉及聚酰胺微胶囊。制备聚酰胺微胶囊的方法也是本发明的目标。包括这些微胶囊的香料组合物和消费品，特别是家居护理或个人护理产品的香气消费品，也是本发明的一部分。
• Chimeric plasmids
  申请人：KABUSHIKI KAISHA YAKULT HONSHA

  公开号：EP0115936A1

  公开（公告）日：1984-08-15

  A chimeric plasmid comprising: (a) a tetracycline resistant gene deriving from pAMal, one of the plasmids retained by Streptococcus faecalis, (b) an ampicillin resistantgene deriving from pACYCl77; one of the vectors applicable to Escherichia coli, and (c) at least one of (i) an area at which repliqation originates deriving from said plasmid pAMal, and (ii) an area at which replication originates deriving from said vector pACYCl77, said tetracycline resistant gene containing only one site at which said chimeric plasmid is recognized and cleaved by the restriction enzyme Ball and said ampicillin resistant gene containing only one site at which said chimeric plasmid is recognized and cleaved by the restriction enzymes Bgll and Pstl. The chimeric plasmid is useful as a vector for conveying a gene into a host cell, usually of a bacterium, and the host can then be employed in biosynthesis of industrial products.

  一种嵌合质粒，包括 (a) 源自 pAMal 的抗四环素基因，pAMal 是粪链球菌保留的质粒之一、 (b) 源自 pACYCl77 的抗氨苄西林基因；pACYCl77 是适用于大肠杆菌的载体之一，以及 (c) (i) 源自所述质粒 pAMal 的复制起源区域和 (ii) 源自所述载体 pACYCl77 的复制起源区域中的至少一个，所述抗四环素基因仅包含一个限制性酶 Ball 可识别和裂解所述嵌合质粒的位点，所述抗氨苄西林基因仅包含一个限制性酶 Bgll 和 Pstl 可识别和裂解所述嵌合质粒的位点。这种嵌合质粒可用作载体，将基因导入宿主细胞（通常是细菌），然后利用宿主细胞进行工业产品的生物合成。
• A method for preventing discloloration of meat products
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0149829A1

  公开（公告）日：1985-07-31

  Discoloration of meat products can be prevented by incorporating ascorbic acids, cistine or/and cisteine, and aspartic acid, and a starch hydrolyzate with a dextrose equivalent of 5 to 30 in addition to said three components.

  除上述三种成分外，还可加入抗坏血酸、肉毒碱或/和肉毒碱、天冬氨酸以及葡萄糖当量为 5-30 的淀粉水解物，以防止肉制品变色。
• Sustained release preparation
  申请人：TEIJIN LIMITED

  公开号：EP0187703A2

  公开（公告）日：1986-07-16

  A sustained release preparation comprising: (a) chitin, chitosan, or a mixture thereof (b) anionic polymer compounds such as those having a carboxyl group, a sulfonic acid group, or a group capable of providing the same, and (c) pharmaceutically active agents. This sustained release preparation can provide the desired sustained-release or dissolution of the pharmaceutically active agents in human organs irrespective of the acidity (i.e., pH conditions) therein.

  一种缓释制剂，包括：(a) 甲壳素、壳聚糖或它们的混合物；(b) 阴离子聚合物化合物，如具有羧基、磺酸基或能提供相同羧基、磺酸基的化合物；(c) 药物活性剂。 这种缓释制剂能在人体器官中提供所需的药物活性剂的缓释或溶解，而不受其中酸度（即 pH 值条件）的影响。